Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1999
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999025340A1 Treatment for alzheimer's disease
05/27/1999WO1999025321A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999018099B1 Aryl thiophene derivatives as pde iv inhibitors
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999WO1999003817A3 Aliphatic propargylamines as cellular rescue agents
05/27/1999WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2310250A1 Treatment for alzheimer's disease
05/27/1999CA2310233A1 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999CA2309744A1 Use of mirtazapine for treating sleep apneas
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999CA2303961A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917571A1 Agouti-related gene
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917537A1 Novel parathyroid hormone-related peptide analogs
05/26/1999EP0917535A1 Neuroactive peptide
05/26/1999EP0917469A1 Methods for inducing bone formation
05/26/1999EP0772448A4 CYCLIC ANALOGS OF PTH AND PTHrP
05/26/1999EP0746545B1 Nipecotic acid derivatives as antithrombic compounds
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217719A Novel benzofuranone derivative and process for producing same
05/26/1999CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
05/26/1999CN1217713A Sulphur derivatives with retroamide bond as endothelin-converting enzyme inhibitors
05/26/1999CN1217662A Water soluble paclitaxel prodrugs
05/26/1999CN1217335A Method for preparing precursor medicine
05/26/1999CN1217332A Metal protease inhibitor, preparation method therefor and medicinal composition containing same
05/26/1999CN1217327A D-proline derivative
05/26/1999CN1217203A Liquor for slimming abdomen
05/25/1999US5907038 Azepanes
05/25/1999US5906996 Tetramine treatment of neurological disorders
05/25/1999US5906993 Anticancer, antitumor agent
05/25/1999US5906988 Methods of treatment using ranolazine and related piperazine derivatives
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999US5906812 Useful for treating intrisic and extrinsic aging such as wrinkles, fine lines, actinic blemishes, dyschromias, dermatitis or scars in human skin; cosmetics
05/25/1999CA2090574C Method of inhibiting nitric oxide formation
05/20/1999WO1999024474A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024451A2 Adenosine a1 receptor agonists
05/20/1999WO1999024449A2 Adenosine a1 receptor agonists
05/20/1999WO1999024433A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
05/20/1999WO1999024423A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999WO1999024420A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999WO1999024401A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024397A1 Benzocycloheptene derivatives
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024063A1 Compositions providing for increased igf-i solubility
05/20/1999WO1999024062A1 Novel igf-i composition and its use
05/20/1999WO1999024061A1 Method for producing igf-1 sustained-release formulations
05/20/1999WO1999024058A2 Neuronal uses of bmp-11
05/20/1999WO1999024057A2 Neuronal uses of bmp-11
05/20/1999WO1999024048A1 Cancer treatment drug
05/20/1999WO1999024044A1 Medicine for promoting cicatrization and containing thrombocytes
05/20/1999WO1999024042A2 Stable antiandrogenic gel composition
05/20/1999WO1999024039A1 Method for reducing mast cell mediated allergic reactions
05/20/1999WO1999024037A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
05/20/1999WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999WO1999024033A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1999024026A2 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999WO1999024024A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
05/20/1999WO1999018213A8 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT
05/20/1999WO1999016753A3 Tricyclic 3-oxo-propanenitrile compounds
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015526A3 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
05/20/1999WO1999015503A3 Process for making diaryl pyridines useful as cox-2 inhibitors
05/20/1999WO1999015191A3 Cytokines having neurotrophic activity
05/20/1999WO1999015160A3 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999006557A3 Mammalian cell membrane proteins; related reagents
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment
05/20/1999WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
05/20/1999WO1998024806B1 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/20/1999DE19750529A1 New heterocyclic alpha-hydroxycarboxylic acid derivatives useful for treating hypertension, chronic coronary insufficiency, asthma, prostate cancer etc.
05/20/1999CA2309538A1 Neuronal uses of bone morphogenetic protein -11
05/20/1999CA2309321A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999CA2309200A1 Adenosine a1 receptor agonists
05/20/1999CA2309177A1 Pyrimidinone compounds and pharmaceutical compositions containing them
1 ... 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 ... 1564